Have to agree with you Peace, it's been frustrating and they haven't met expectations. Lot's of excuses rolled out, but cash in bank and share price appreciation is the game for investors - and that is a concern.
They seem to have toned down the rhetoric at least on new alliances. Hopefully they will over deliver on that and they're not just being bullish on a weak pipeline !!??
I think Roche is due to extend, or not, by the end of March. If they extend it will be a big milestone. Pfizer seems to be open ended despite their collaboration agreement having expired, so who knows?
Ironically it seems they have enough cash to see them through the next 12 months or so, with the R&D funds, so hopefully they can concentrate on delivery and not worry so much about their survival.
Here's hoping....
PYC Price at posting:
2.7¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)